These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36637817)

  • 1. The CRISPR Patent Ruling and Implications for Medicine.
    Paradise J
    JAMA; 2023 Feb; 329(6):461-462. PubMed ID: 36637817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR patent ruling leaves license holders scrambling.
    Cohen J
    Science; 2017 Feb; 355(6327):786. PubMed ID: 28232532
    [No Abstract]   [Full Text] [Related]  

  • 3. Governing Human Germline Editing Through Patent Law.
    Sherkow JS; Adashi EY; Cohen IG
    JAMA; 2021 Sep; 326(12):1149-1150. PubMed ID: 34459849
    [No Abstract]   [Full Text] [Related]  

  • 4. The morality and ethics governing CRISPR-Cas9 patents in China.
    Peng Y
    Nat Biotechnol; 2016 Jun; 34(6):616-8. PubMed ID: 27281418
    [No Abstract]   [Full Text] [Related]  

  • 5. The Patent Landscape for CRISPR Genome Editing in Australia.
    Foo N; Adesanya O; Nielsen J; Nicol D
    J Law Med; 2023 Jul; 30(2):286-309. PubMed ID: 38303616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-editing technologies and patent landscape overview.
    Benahmed-Miniuk F; Kresz M; Kanaujiya JK; Southgate CD
    Pharm Pat Anal; 2017 May; 6(3):115-134. PubMed ID: 28534435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR, Patents, and the Public Health.
    Sherkow JS
    Yale J Biol Med; 2017 Dec; 90(4):667-672. PubMed ID: 29259531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR patent estate splinters.
    Sheridan C
    Nat Biotechnol; 2017 Sep; 35(9):808-809. PubMed ID: 28898216
    [No Abstract]   [Full Text] [Related]  

  • 9. Advancing biotechnology with CRISPR/Cas9: recent applications and patent landscape.
    Ferreira R; David F; Nielsen J
    J Ind Microbiol Biotechnol; 2018 Jul; 45(7):467-480. PubMed ID: 29362972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major CRISPR patent decision won't end tangled dispute.
    Ledford H
    Nature; 2022 Mar; 603(7901):373-374. PubMed ID: 35264807
    [No Abstract]   [Full Text] [Related]  

  • 11. The Birth of CRISPR Inc.
    Cohen J
    Science; 2017 Feb; 355(6326):680-684. PubMed ID: 28209854
    [No Abstract]   [Full Text] [Related]  

  • 12. Dealing with Patent Fragmentation in Genetics: Can Patent Pools Facilitate the Development of CRISPR Gene-Editing Technology?
    Stasi A; Rodrigues IP
    J Law Med; 2019 Jul; 26(4):866-873. PubMed ID: 31682364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for Optimization of the Clustered Regularly Interspaced Short Palindromic Repeat-Based Genome Editing System for Enhanced Editing Specificity.
    Wang YM; Wang HZ; Jian YZ; Luo ZT; Shao HW; Zhang WF
    Hum Gene Ther; 2022 Apr; 33(7-8):358-370. PubMed ID: 34963339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas Advancement in Molecular Diagnostics and Signal Readout Approaches.
    Ahmed MZ; Badani P; Reddy R; Mishra G
    J Mol Diagn; 2021 Nov; 23(11):1433-1442. PubMed ID: 34454111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does CRISPR-Cas open new possibilities for patents or present a moral maze?
    Webber P
    Nat Biotechnol; 2014 Apr; 32(4):331-3. PubMed ID: 24714479
    [No Abstract]   [Full Text] [Related]  

  • 17. Inventive steps: the CRISPR patent dispute and scientific progress: The recent patent decisions about CRISPR tell us a lot about how advances in biology are actually made-and how they are not.
    Sherkow JS
    EMBO Rep; 2017 Jul; 18(7):1047-1051. PubMed ID: 28536246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR heavyweights battle in US patent court.
    Reardon S
    Nature; 2016 Dec; 540(7633):326-327. PubMed ID: 27974781
    [No Abstract]   [Full Text] [Related]  

  • 19. CRISPR, surrogate licensing, and scientific discovery.
    Contreras JL; Sherkow JS
    Science; 2017 Feb; 355(6326):698-700. PubMed ID: 28209863
    [No Abstract]   [Full Text] [Related]  

  • 20. Use the patent system to regulate gene editing.
    Parthasarathy S
    Nature; 2018 Oct; 562(7728):486-488. PubMed ID: 30353159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.